11 May 2021 : Original article
Surgical Outcome of Pulmonary Metastasectomy for Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
Yong Ho Jeong1ABCDEFG, Shin Hwang2ACDEF, Geun Dong Lee1AB, Se Hoon Choi1AB, Hyeong Ryul Kim1AB, Yong-Hee Kim1AB, Seung-Il Park1AB, Dong Kwan Kim1ABCDEFG*DOI: 10.12659/AOT.930383
Ann Transplant 2021; 26:e930383
Table 3 Univariate and multivariate analysis of factors associated with patient survival.
Variable | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
p-Value | HR | 95% CI | p-Value | |
Recurrence-free period | 0.014 | 0.56 | 0.37–0.89 | 0.008 |
Number of pulmonary metastasis | 0.43 | |||
Size of pulmonary metastasis | 0.41 | |||
Level of AFP at metastasectomy | 0.027 | 2.79 | 1.36–5.72 | 0.005 |
Postmetastasectomy chemotherapy | 0.003 | 3.68 | 1.49–9.07 | 0.005 |
AFP – alpha-fetoprotein; HR – hazard ratio; CI – confidence interval. |